PMC:7502678 / 20164-20273
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T105 | 56-59 | Disease | denotes | ASM | http://purl.obolibrary.org/obo/MONDO_0020333 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T24 | 95-108 | Chemical | denotes | levetiracetam | http://purl.obolibrary.org/obo/CHEBI_6437 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 412 | 95-108 | Chemical | denotes | levetiracetam | MESH:D000077287 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T153 | 0-109 | Sentence | denotes | Most respondents did not notice lack of availability of ASM, with the exception of long acting levetiracetam. |